1Fang M, Toher J, Morgan M,et al. Genomic differences betweenestrogen receptor(ER)-positive and ER-negative human breastcarcinoma identified by single nucleotide polymorphism arraycomparative genome hybridization analysis. Cancer. 2011, 117(10):2024-2034.
2Gruver AM, Portier BP, Tubbs RR. Molecular pathology of breastcancer: the journey from traditional practice toward embracing thecomplexity of a molecular classification. Arch Pathol Lab Med,2011, 135 (5):544-557.
3Veronesi U, Cascinelli N, Marlani L, et al. Twenty year follow upof a randomized study comparing breast conserving surgerywithradicalmastectrany for eaily breast cancer. N Engle J Med, 2002,347(16):1227-1232.
4Fisher B,Anderson S,Bryant J, et al. Twenty year follow-up of arandomized trial comparing total mastectomy, lumpectomy, andlumpectomy plusirradiation for the treatment of invasive breastcancer. N Engle J Med, 2002, 347(16):1233-1241.
3LU Wenli. LI Haixiang , QIAN Biyao , et al. The clinical characteristics and prognosis of Chinese early stage breast cancer patients: a retrospective study [J]. Breast Journal, 2010. 16(3): 331-333.
4JELOV AC D, ARMSTRONG D K. Recent progress in the diagnosis and treatment of ovarian cancer [J]. CA-a Cancer Journal for Clinicians, 2011, 61(3): 183-203.
5KWON I K, LEE S C, HAN B. et al. Analysis on the current status of targeted drug delivery to tumors [J]. Journal of Controlled Release. 2012, 164(2): 108-114.
6SAFAVY A Recent developments in taxane drug deliv- ery [J]. Current Drug Delivery, 2008. 5(1): 42-54.
7SHOICHET M S. TATOR C H. POON P. et al. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord [J]. Progress in Brain Research. 2007, 161(1): 385-392.
8WIRK B. PEREZ E. Role of gemcitabine in breast cancer management: an update [J]. Seminars in Oncology, 2006, 33 (SI): S6-S14.
9PAOLINO D, COSCO D, RACANICCHI L. et al. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution , pharmacokinetic features and in vivo antitumor activity [J]. Journal of Controlled Release, 2010, 144(2): 144-150.
10ELSTAD N L, FOWERS K D. ONCOGELCReGel/paclitaxel i-clinical applications for a novel paclitaxel delivery system [J]. Advanced Drug Delivery Reviews, 2009,61(10): 785-794.
